Celldex Therapeutics logo
Celldex Therapeutics CLDX
$ 26.28 -0.45%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Celldex Therapeutics Income Statement 2011-2024 | CLDX

Annual Income Statement Celldex Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

2.33 M 2 M 1.33 M 641 K 33.5 M 64.2 M 360 M 330 M 806 M 1.91 B 2.11 B 420 M 177 M

Shares

48.4 K 46.9 K 42.9 K 29.6 K 14.5 M 10.4 M 8.57 M 6.77 M 6.47 M 5.96 M 5.32 M 3.85 M 2.63 M

Historical Prices

48 42.7 31 21.6 2.32 7.65 41.4 48.9 124 321 387 112 71.1

Net Income

-141 M -112 M -70.5 M -59.8 M -50.9 M -151 M -93 M -129 M -127 M -118 M -81.6 M -59.1 M -44.8 M

Revenue

6.88 M 2.36 M 4.65 M 7.42 M 3.57 M 9.54 M 12.7 M 6.79 M 5.48 M 3.59 M 4.11 M 11.2 M 9.26 M

Cost of Revenue

300 K 100 K 100 K 200 K 100 K 700 K 700 K 1.6 M - - - - -

Gross Profit

- - - - - - - - 5.48 M 3.59 M 1.78 M 427 K 146 K

Operating Income

-155 M -115 M -71.2 M -63.4 M -55 M -156 M -122 M -133 M -130 M -122 M -81.4 M -58.1 M -43.4 M

Interest Expense

- - - - - - - - - - 927 K 1.58 M 1.8 M

EBITDA

-152 M -112 M -68.2 M -59.4 M -49.7 M -76.2 M -108 M -132 M -129 M -121 M -80.4 M -57 M -41.5 M

Operating Expenses

- - - - 58.1 M 85.9 M 122 M 140 M 135 M 126 M 83.2 M 58.5 M 43.6 M

General and Administrative Expenses

30.9 M 27.2 M 20.5 M 14.5 M 15.4 M 19.3 M 25 M 36 M 33.8 M 20.6 M 14.8 M 10 M -

All numbers in USD currency

Quarterly Income Statement Celldex Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

66.3 K 66 K 58.9 K 55.9 M 47.3 K 47.3 K 47.2 K 47.2 M 46.9 K 46.8 K 46.7 K 46.7 M 45.5 M 39.6 M 39.6 M 39.6 M 39.3 M 22.1 M 17.4 M 17 M 15.3 M 14 M 12.3 M 12 M 10.9 M 9.83 M 9.37 M 9.23 M 130 M 125 M 123 M 121 M 101 M 98.8 M 98.7 M 98.7 M 98.6 M 98.5 M 92.4 M 89.6 M 89.4 M 89.4 M 89.3 M 89.2 M 81 M 80.9 M 74 M 64.4 M 59.5 M 58.7 M 50.1 M 44.2 M 44.1 M 37.5 M 32 M

Net Income

-42.1 M -35.8 M -32.8 M - -38.3 M -30.5 M -29.4 M - -26.8 M -36 M -23 M - -20.5 M -13.4 M -16.5 M -21.9 M -14.2 M -11 M -12.6 M -10.4 M -11.4 M -11.8 M -17.2 M -9.4 M -7.24 M -16.4 M -118 M -3.84 M -26.4 M -28.6 M -34.3 M -32.3 M -29.6 M -32 M -34.7 M -32.7 M -32 M -32.4 M -30.2 M -31.8 M -28.1 M -28.3 M -29.9 M -22.1 M -23.1 M -19 M -17.3 M -16.8 M -15 M -13.8 M -13.5 M -12.7 M -11.8 M -10.2 M -10.1 M

Revenue

3.19 M 2.5 M 156 K - 1.52 M 268 K 967 K - 407 K 163 K 174 K - 153 K 3.48 M 685 K 3.79 M 668 K 236 K 2.73 M 887 K 546 K 715 K 1.42 M 1.76 M 941 K 2.76 M 4.07 M 3.46 M 3.92 M 3.83 M 1.53 M 1.87 M 2.22 M 1.39 M 1.3 M 1.79 M 1.03 M 2.18 M 486 K 1.48 M 1.1 M 592 K 416 K 620 K 980 K 97 K 2.41 M 3.65 M 3.11 M 2.01 M 2.43 M 2.43 M 2.36 M 1.95 M 2.52 M

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-52.1 M -46.3 M -40.6 M - -41.2 M -33.2 M -32.5 M - -27.7 M -36.4 M -23.3 M - -20.8 M -13.4 M -16.6 M - -14.3 M -11.4 M -12.9 M - -11.8 M -12.3 M -17.9 M - -7.76 M -16.9 M -120 M - -32 M -28.9 M -35.1 M - -30 M -32.4 M -35.7 M - -32.4 M -32.8 M -31 M - -30.3 M -28.5 M -31.5 M - -23.3 M -18.7 M -17.4 M - -14.8 M -13.5 M -13.3 M - -11.5 M -9.88 M -9.66 M

Interest Expense

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 13 K 519 K 310 K - 381 K 411 K 433 K - 438 K 434 K 485 K

EBITDA

- - -39.8 M - - - -31.7 M - -25.5 M -34.8 M -22.4 M - -18.5 M -11.9 M -15.9 M - -11.2 M -9.05 M -11.7 M - -8.13 M -9.75 M -16.6 M - -4.91 M -16.9 M -119 M - -28.6 M -26.6 M -33.7 M - -27.9 M -30.9 M -35 M - -30.2 M -31.4 M -30.3 M - -28.6 M -27.4 M -30.9 M - -21.8 M -17.7 M -16.9 M - -13.2 M -12.4 M -12.7 M - -9.78 M -8.75 M -9.1 M

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

10.1 M 9.13 M 9.1 M - 8.22 M 7.22 M 6.64 M - 6.53 M 7.15 M 6.91 M - 5.82 M 4.31 M 4.12 M - 3.64 M 3.53 M 3.67 M - 3.4 M 3.91 M 4.9 M - 3.72 M 5.62 M 5.59 M - 5.35 M 6.53 M 7.23 M - 6.95 M 7.79 M 9.31 M - 8.49 M 8.18 M 6.09 M - 5 M 4.79 M 4.58 M - 3.58 M 3.41 M 3.14 M - 2.84 M 2.22 M 2.32 M - 2.27 M 2.24 M 2.34 M

All numbers in USD currency